Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A syndromic genetic hearing loss is characterized by congenital nerve deafness and piebaldness with no ocular albinism. It has been described in one large pedigree. Transmission is X-linked with affected males presenting with profound sensorineural deafness and severe pigmentary abnormalities of the skin, and carrier females presenting with variable hearing impairment without any pigmentary changes. The causative gene has been mapped to Xq26.3-q27.1.
Features include: Albinism, Patchy hypo- and hyperpigmentation, Ocular albinism, and Piebald skin depigmentation and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 2 | Patchy hypo- and hyperpigmentation, Piebald skin depigmentation |
Biomarker and diagnostic research for albinism-hearing loss syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for albinism-hearing loss syndrome.
234 publications have been identified in PubMed for albinism-hearing loss syndrome. Research spans Basic Science / Preclinical (34%), Review / Meta-Analysis (31%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 79 | 34% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 5:05 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about albinism-hearing loss syndrome
1 |
Ocular albinism |
Ears | 1 | Congenital sensorineural hearing impairment |
Pregnancy and birth | 1 | Congenital sensorineural hearing impairment |
Research summaries
73 |
31% |
Patient case studies | 35 | 15% |
Disease patterns and progression | 25 | 11% |
Testing and diagnosis research | 9 | 4% |
New treatment approaches | 8 | 3% |
Clinical study results | 5 | 2% |
Karsonovich T (2026). [PMID: 30422477](https://pubmed.ncbi.nlm.nih.gov/30422477/). *Unknown Journal*. [Basic Science / Preclinical]
Federico JR (2026). [PMID: 30085560](https://pubmed.ncbi.nlm.nih.gov/30085560/). *Unknown Journal*. [Clinical Trial Publication]
Alok A (2026). [PMID: 32644595](https://pubmed.ncbi.nlm.nih.gov/32644595/). *Unknown Journal*. [Basic Science / Preclinical]
Mauriac SA (2026). [PMID: 40994011](https://pubmed.ncbi.nlm.nih.gov/40994011/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Review / Meta-Analysis]
Aldè M (2026). [PMID: 42114454](https://pubmed.ncbi.nlm.nih.gov/42114454/). *Int J Pediatr Otorhinolaryngol*. [Clinical Trial Publication]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Case Report / Case Series]
Firla A (2026). [PMID: 41917173](https://pubmed.ncbi.nlm.nih.gov/41917173/). *Dermatologie (Heidelb)*. [Epidemiology / Natural History]
Yuan Q (2026). [PMID: 41539473](https://pubmed.ncbi.nlm.nih.gov/41539473/). *J Genet Genomics*. [Basic Science / Preclinical]
VanSickle EA (2026). [PMID: 41410504](https://pubmed.ncbi.nlm.nih.gov/41410504/). *Am J Med Genet A*. [Review / Meta-Analysis]
Roberts JP (2026). [PMID: 42001184](https://pubmed.ncbi.nlm.nih.gov/42001184/). *Orphanet J Rare Dis*. [Diagnostic / Biomarker]
AI-curated news mentioning albinism-hearing loss syndrome
Updated Jun 5, 2026
A pilot study explores the dyadic adjustment and quality of life in individuals with albinism, highlighting their shared experiences with loved ones. This research contributes to understanding the psychosocial aspects of living with albinism.
A recent study highlights the unique epidemiological and clinical features of albinism in Europe, providing insights into its management. This research contributes to the understanding of albinism, which affects individuals with varying degrees of pigmentation.